GNE executed massive share buybacks ($37K to $10.4M) while revenue surged 280% but profitability collapsed 36%, indicating potential value destruction despite growth.
The dramatic increase in share buybacks combined with declining profitability on massive revenue growth suggests management may be returning cash to shareholders while the business struggles with margin compression. The 280% revenue increase with declining net income indicates serious operational efficiency issues or one-time charges that warrant immediate investor scrutiny.
GNE demonstrated explosive top-line growth with revenue increasing 280% to $425.2M and operating cash flow growing 13% to $70.7M, while simultaneously executing aggressive share buybacks that increased over 28,000% to $10.4M and cutting capital expenditures by 82%. However, this growth came at a significant cost as net income plummeted 36% to $12.6M despite the revenue surge, and total liabilities increased 31% to $191.7M, suggesting the company is struggling with profitability and leverage while prioritizing shareholder returns over reinvestment. The combination of margin compression, reduced capex, and aggressive buybacks signals potential value destruction masked by impressive revenue growth.
Share repurchases increased 28124.3% — management returning capital, signals confidence in intrinsic value.
R&D investment increased 430.8% — signals commitment to future product development, though near-term margin impact.
Strong top-line growth of 279.9% — accelerating demand or successful expansion into new markets.
Capex reduced 82.3% — investment cycle winding down or capital discipline; may improve near-term free cash flow.
Net income declined 35.6% — review whether driven by operations, interest costs, or non-recurring items.
Liabilities grew 31.3% — significant increase in debt or obligations, assess impact on financial flexibility.
Inventory reduced 16.5% — lean inventory management or demand outpacing supply.
Operating cash flow grew 13.2% — strong conversion of earnings to cash, healthy business fundamentals.
Asset base grew 12.3% — expansion through organic growth, acquisitions, or capital deployment.
Current liabilities rose 11.8% — increased short-term obligations, watch current ratio.
See what changed in your portfolio's filings
500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.
Try Tracenotes free →